Oakmark Global Strategy adds AstraZeneca, exits General Motors in Q4

Posted on by wpadmin
  • Oakmark Global Strategy returned 5.04% during the fourth quarter of 2025, compared to the MSCI World Index’s 3.12% gain.
  • The strategy fund initiated a position in AstraZeneca (AZN) and Gartner (IT), and exited General Motors (GM), Naspers (NAPRF), Novartis (NVS), and Worldline (WWLNF).
  • Source: Fund Letter

Leave a Reply

Your email address will not be published. Required fields are marked *